Daniel SW Tan

Trials

Studies that name Daniel SW Tan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:15 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06956248 · Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)

  National Cancer Centre, Singapore · recruiting · Solid Tumor · principal investigator
• N/A
  NCT06418412 · A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC

  National Cancer Centre, Singapore · recruiting · Advanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung Cancer · study chair
• Ph2
  NCT04946968 · Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

  National Cancer Centre, Singapore · active not recruiting · Advanced Solid Tumours, Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma · principal investigator
• N/A
  NCT04087473 · Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

  National Cancer Centre, Singapore · completed · Non-small Cell Lung Cancer, ALK-Positive Lung Cancer · principal investigator
• Ph1
  NCT03711422 · Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC

  National Cancer Centre, Singapore · terminated · Non-small Cell Lung Cancer, Leptomeningeal Disease, Central Nervous System Metastases · principal investigator
• N/A
  NCT02806388 · Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project

  National Cancer Centre, Singapore · recruiting · Solid Tumor · principal investigator
• Ph2
  NCT02804776 · PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery

  National Cancer Centre, Singapore · completed · Non-small Cell Lung Cancer · principal investigator
• Ph1
  NCT01570296 · A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR

  National Cancer Centre, Singapore · completed · Non-Small Cell Lung Cancer, Solid Tumors · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 20 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.